Pharma Exec Accuses CFDA Officials Of Favoritism
This article was originally published in PharmAsia News
Executive Summary
An executive of two Chinese drug makers, Henan Yisheng Pharmaceuticals and its parent, Liaoning Yisheng Biological Pharmaceuticals, has joined with others to accuse three officials of the China FDA of wrongdoing.
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.